Kobe Company is conducting a project with an up$-$front cost at t $=0$ of $$1,100,000.$ The project's subsequent cash flows depends on whether a competitor's product is approved by FDA. There is a $60\%$ chance that the competitive product will be rejected, in which case the company's expected cash flows will be $$500,874$ at the end of each of the next four years $($t $=1$ to $4).$ There is a $40\%$ chance that the competitor's product will be approved, in which case the expected cash flows will be only $$158,791$ in t $=1$ to $4.$ The company will know for sure one year from today whether the competitor's product has been approved.

If the company waits a year, the project's up$-$front cost at t $=1$ will remain at $$1,100,000.$ The subsequent cash flows will also remain the same with the same probabilities as no waiting, but will be received only for three years $($t $=2$ to $4).$ All cash flows are discounted at the company's WACC of $10\%.$

What will the NPV at t$=0$ for each of the two strategies be$?$ Round your answer to the nearest dollar, e$.$g$.,$ xxx$,$xxx$.($Hint: Refer to the Evaluation of Investment Timing Option example in Real Options.$)$

NPV at t$=0$ if the company proceeds today $=$ $

NPV at t$=0$ if the company waits a year $=$ $